Trials / Sponsors / Elazığ Mental Health and Diseases Hospital
Elazığ Mental Health and Diseases Hospital
Other Government · 11 registered clinical trials — 7 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Psychiatric Symptom Characteristics in Methamphetamine-Induced Psychosis With and Without Lifetime Cannabis Us Methamphetamine Induced Psychosis, Cannabis Use | — | 2026-03-16 |
| Not Yet Recruiting | Cognitive Disengagement Syndrome in Functional Neurological Symptom Disorder Functional Neurological Symptom Disorder | — | 2026-03-09 |
| Not Yet Recruiting | LRFN5 and OLFM4 in Schizoaffective Disorder Schizoaffective Disorder | — | 2026-03-02 |
| Recruiting | LRFN5 and OLFM4 in Methamphetamine-Induced Psychosis Methamphetamine Use Disorder, Methamphetamine-induced Psychosis | — | 2025-09-01 |
| Completed | LRFN5 and OLFM4 in Bipolar Disorder Bipolar Disorder (BD) | — | 2025-07-07 |
| Recruiting | IL-33, sST2, and CRP in Panic Disorder Panic Disorder | — | 2025-07-07 |
| Completed | α-N-acetylgalactosaminidase in Methamphetamine Psychosis Methamphetamine Use Disorder, Methamphetamine-induced Psychosis | — | 2025-05-01 |
| Completed | α-N-acetylgalactosaminidase Levels in Panic Disorder Panic Disorder | — | 2025-05-01 |
| Completed | LRFN5 and OLFM4 in Schizophrenia Schizophrenia Disorder | — | 2025-04-27 |
| Recruiting | ECG Findings in Methamphetamine Use Methamphetamine Use Disorder, Methamphetamine Induced Psychosis | — | 2025-04-07 |
| Recruiting | Psychiatric Symptom Predictors in Methamphetamine-Induced Psychosis Methamphetamine Induced Psychosis | — | 2025-02-03 |